Melbourne – Australia's technology capital
Melbourne has earned a reputation as Australia's technology hub and is home to more than 8000 IT companies and half of the nation's top 20 technology companies, including many international firms such as IBM, Microsoft and Intel.
As part of the professional services sector, digital technologies is included in the Victorian Government's priority sectors and plays a major role in our economy generating A$34 billion in annual revenue and approximately A$2.5 billion in exports every year.
We produce more ICT graduates than any other state in Australia – graduates who enter the workforce as highly skilled professionals offering a global competitive advantage. Our world-class universities help Melbourne lead the way as Australia's digital technology state by providing cutting-edge learning environments and facilities, such as the Royal Melbourne Institute of Technology's (RMIT) innovative Design Hub.
Melbourne has established Australia's largest cyber security cluster – Data61 – comprising six of Victoria's best cyber security companies, eight of our top universities, and Australia's leading digital research organisation. The cluster forms an important collaborative relationship focused on improving engagement between research and business, and driving innovative responses to the major security concerns of our digitised society.
Computer scientists from Swinburne University of Technology have joined forces with Melbourne's Royal Children's Hospital (RCH), Victoria's Transport Accident Commission (TAC) and The Brainary to research and develop specialised artificial intelligence software for NAO – the humanoid robot.
The software has been designed to enhance therapeutic outcomes for children undergoing intensive physical rehabilitation. According to a recent Swinburne news article (December 2016), lead researcher of the project Dr Chris McCarthy claims the children's interactions with the robot have shown very promising results and "the technology is now ready for use in formal clinical trials."